Alcohol Research-Related Resource Award (R24 Clinical Trial Not Allowed)
Issued by National Institutes of Health · via Grants.gov — US federal funding opportunities
- Published
- 30 Nov 2023
- Closes
- 25 Sept 2026, 23:59 UTC
- Reference
- PAR-24-071
- Location
- United States
- Sector
- Healthcare & Pharma
Details
The purpose of the Resource-Related Research Projects (R24) grant is to support investigator-initiated resources designed to provide materials and services to support and advance biomedical research on a national basis. An R24 resource grant mechanism is a non-hypothesis-driven activity to provide data, materials, tools, or services that are essential to making timely, high quality, and cost-efficient progress in a field. Hypothesis-driven research applications should not be submitted in response to this program announcement but to another mechanism that encourages this type of research. The resource should be available to any qualified investigator, and should be highly quality controlled, and not duplicate resources available commercially or through other sources. Resources should be designed to provide services to the broad alcohol research community and should not be limited by any specific regional focus. Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
CFDA number(s): 93.273
Federal funding opportunity published on Grants.gov. Applications are submitted through Grants.gov — see the official listing.
Before you bid on this tender
A quick checklist to help you decide whether to bid and prepare a compliant submission for this healthcare & pharma opportunity. Always verify the details on the official source.
- Confirm the exact closing date and time (and time zone) on the official portal — deadlines are strict and can be revised by a corrigendum.
- Read the full notice and every attached document, including the scope, specifications and any bill of quantities or terms of reference.
- Check the eligibility criteria — prior similar experience, annual turnover, certifications and registrations — and make sure you qualify before investing effort.
- Prepare any earnest-money deposit (EMD) or bid security and the required formats early; missing or wrongly-formatted documents are a common cause of rejection.
- Note how bids must be submitted (online or physical), in what format, and whether a digital signature or portal registration is required.
- Watch for corrigenda and clarifications right up to the deadline — requirements and dates can change.
More Healthcare & Pharma tenders
- Prevention AssistantMENTOR · Venezuela
- Annual maintenance contract for the Civil work in Centenary Super Specialty building S.S. Hospital, IMS, BHU, Varanasi.Banaras Hindu University · India
- Accessories for Multipara Monitor Model Ultima Prime Make BPLDr. Ram Manohar Lohia Hospital · Procurement Section · India
- CAMC for HPLC SystemCouncil of Scientific and Industrial Research · IGIB-Delhi - CSIR · Purchase-IGIB - CSIR · India
- Acquérir 6 véhicules de transport adaptés pour l'acheminement des produits de santé dans les 6 wilayasUGP SWEDD
FreeTender mirrors this notice for reference. Verify the details and bid on the official portal.
Verify & apply on the official portal →